PRE
Prenetics Global Ltd
NASDAQ: PRE · HEALTHCARE · DIAGNOSTICS & RESEARCH
$16.71
-4.02% today
Updated 2026-04-30
Market cap
$310.15M
P/E ratio
—
P/S ratio
3.36x
EPS (TTM)
$-3.79
Dividend yield
—
52W range
$5 – $24
Volume
0.2M
Prenetics Global Ltd (PRE) Financial statements
SEC filings — annual and quarterly data.
Profit margin
-63.10%
Operating margin
-33.30%
ROE
-31.80%
ROA
-11.00%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2003 | $3.87B | $467.68M | 12.86% | 12.86% | 12.08% |
| 2004 | $4.17B | $492.35M | 12.56% | 12.56% | 11.80% |
| 2005 | $4.21B | — | — | — | — |
| 2006 | $4.19B | $749.33M | 21.91% | 21.91% | 17.89% |
| 2007 | $4.15B | $717.81M | 22.94% | 22.94% | 17.29% |
| 2008 | $4.00B | $46.57M | 2.67% | 2.67% | 1.16% |
| 2009 | $5.33B | $1.54B | 33.17% | 32.41% | 28.81% |
| 2010 | $5.90B | $852.55M | 19.64% | 18.48% | 14.44% |
| 2011 | $5.40B | — | — | — | — |
| 2012 | $5.56B | $1.13B | 25.34% | 24.77% | 20.40% |
| 2013 | $5.59B | $664.01M | 15.39% | 14.91% | 11.88% |
| 2014 | $6.48B | $1.05B | 21.02% | 20.59% | 16.29% |
| 2015 | $5.48B | $104.38M | 12.21% | 11.72% | 1.91% |
| 2019 | $9.23M | $-20.14M | 29.41% | -225.31% | -218.15% |
| 2020 | $65.18M | $-1.94M | 40.42% | -1.53% | -2.98% |
| 2021 | $12.53M | $-174.01M | 28.75% | -452.11% | -1,388.44% |
| 2022 | $13.16M | $-190.45M | 27.48% | -501.53% | -1,446.78% |
| 2023 | $21.74M | $-62.72M | 40.61% | -238.73% | -288.48% |
| 2024 | $30.62M | $-46.30M | 50.29% | -157.23% | -151.22% |
| 2025 | $92.39M | $-58.32M | 52.98% | -40.46% | -63.13% |